Authors:
Graf, WD
Unis, AS
Yates, CM
Sulzbacher, S
Dinulos, MB
Jack, RM
Dugaw, KA
Paddock, MN
Parson, WW
Citation: Wd. Graf et al., Catecholamines in patients with 22q11.2 deletion syndrome and the low-activity COMT polymorphism, NEUROLOGY, 57(3), 2001, pp. 410-416
Authors:
Furukawa, Y
Graf, WD
Wong, H
Shimadzu, M
Kish, SJ
Citation: Y. Furukawa et al., Dope-responsive dystonia simulating spastic paraplegia due to tyrosine hydroxylase (TH) gene mutations, NEUROLOGY, 56(2), 2001, pp. 260-263
Citation: Wd. Graf et Oe. Oleinik, The study of neural tube defects after the human genome project and folic acid fortification of foods, EUR J PED S, 10, 2000, pp. 9-12
Authors:
Duchowny, M
Pellock, JM
Graf, WD
Billard, C
Gilman, J
Casale, E
Womble, G
Risner, M
Manasco, P
Citation: M. Duchowny et al., A placebo-controlled trial of lamotrigine add-on therapy for partial seizures in children, NEUROLOGY, 53(8), 1999, pp. 1724-1731
Citation: Wd. Graf et Mj. Noetzel, Radical reactions from missing ceruloplasmin - The importance of a ferroxidase as an endogenous antioxidant, NEUROLOGY, 53(3), 1999, pp. 446-447
Citation: Wd. Graf et al., Outcome in severe pediatric Guillain-Barre syndrome after immunotherapy orsupportive care, NEUROLOGY, 52(7), 1999, pp. 1494-1497